Bharat Parenterals Shareholders Unanimously Approve Preferential Issue and Investment Limits
Bharat Parenterals Ltd 路 Extra Ordinary General Meeting 路 25 Oct 2026, 8:04 pm
Bharat Parenterals Shareholders Unanimously Approve Preferential Issue and Investment Limits Bharat Parenterals Limited submitted revised voting results for its EGM held on 23rd Oct'26 to rectify shareholder categorisation errors between Public鈥揑nstitutions and Public鈥揘on-Institutions, with no impact on vote counts or outcomes. Shareholders passed both special resolutions with 100% approval across 4,879,194 votes polled (78.71% turnout). Key approvals comprise the issuance of equity shares on a preferential basis and authorization to make investments, extend loans, provide guarantees, and offer security exceeding limits under Section 186(2) of the Companies Act, 2013.
Original exchange filing (PDF)
More announcements from Bharat Parenterals Ltd
- Intimation for receipt of Establishment Inspection Report from US FDA by Innoxel Lifesciences Pvt Ltd., a subsidiary company of Bharat Parenterals Limited. 路 05 Nov 2026
- Transcript of Earnings Conference Call of Q2FY27. 路 02 Nov 2026
- Audio Recording of Q2FY27 Earnings Conference Call. 路 30 Oct 2026
- Investor Presentation for the Quarter and Half Year ended on September 30, 2026. 路 29 Oct 2026
- Un-Audited Standalone and Consolidated Financial Results For the Quarter and Half Year Ended On September 30, 2026. 路 29 Oct 2026
- Outcome of the Meeting of the Board of Director of Bharat Parenterals Limited held on October 29, 2026 路 29 Oct 2026
- Approval of Preferential Issue by Shareholders of the Company through EGM Held on October 23, 2026. 路 25 Oct 2026
- Approval of Preferential Issue by shareholders of the company through EGM held on October 23, 2026. 路 24 Oct 2026
